Glenview Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.2M Buy
48,703
+637
+1% +$56.1K 0.06% 173
2026
Q2
$3.76M Sell
48,066
-3,090
-6% -$249K 0.05% 180
2026
Q1
$4.43M Sell
51,156
-423
-0.8% -$40.5K 0.07% 167
2025
Q4
$4.95M Buy
51,579
+1,726
+3% +$168K 0.08% 157
2025
Q3
$4.75M Sell
49,853
-2,996
-6% -$275K 0.08% 159
2025
Q2
$4.61M Sell
52,849
-192
-0.4% -$16.3K 0.08% 156
2025
Q1
$4.77M Sell
53,041
-1,055
-2% -$94.4K 0.09% 142
2024
Q4
$4.32M Buy
54,096
+15
+0% +$1.3K 0.08% 149
2024
Q3
$4.87M Buy
54,081
+384
+0.7% +$32.3K 0.09% 143
2024
Q2
$4.23M Sell
53,697
-1,731
-3% -$142K 0.09% 140
2024
Q1
$4.83M Buy
55,428
+2,658
+5% +$227K 0.1% 137
2023
Q4
$4.35M Sell
52,770
-14,187
-21% -$1.08M 0.11% 135
2023
Q3
$5.25M Sell
66,957
-1,868
-3% -$156K 0.14% 116
2023
Q2
$6.06M Sell
68,825
-1,513
-2% -$130K 0.17% 106
2023
Q1
$5.67M Sell
70,338
-1,498
-2% -$122K 0.17% 107
2022
Q4
$5.58M Sell
71,836
-5,051
-7% -$409K 0.19% 106
2022
Q3
$6.21M Sell
76,887
-12,569
-14% -$1.13M 0.24% 98
2022
Q2
$8.03M Sell
89,456
-39,328
-31% -$3.98M 0.3% 87
2022
Q1
$14.3M Sell
128,784
-72,471
-36% -$7.66M 0.46% 65
2021
Q4
$20.8M Sell
201,255
-882
-0.4% -$102K 0.69% 46
2021
Q3
$25.3M Buy
202,137
+3,082
+2% +$399K 0.98% 28
2021
Q2
$24.7M Buy
199,055
+7,962
+4% +$1,000K 0.95% 29
2021
Q1
$22.6M Buy
191,093
+5,014
+3% +$588K 0.97% 30
2020
Q4
$21.8M Buy
186,079
+3,158
+2% +$348K 1.01% 29
2020
Q3
$19M Buy
182,921
+13,659
+8% +$1.37M 0.99% 32
2020
Q2
$15.5M Buy
169,262
+11,239
+7% +$1.08M 0.88% 34
2020
Q1
$14.3M Buy
158,023
+10,724
+7% +$1.14M 0.99% 29
2019
Q4
$16.7M Buy
147,299
+5,911
+4% +$649K 0.93% 34
2019
Q3
$15.4M Buy
141,388
+6,435
+5% +$671K 0.93% 32
2019
Q2
$13.1M Buy
134,953
+28,501
+27% +$2.6M 0.82% 39
2019
Q1
$9.7M Buy
106,452
+49,890
+88% +$4.47M 0.62% 50
2018
Q4
$5.14M Buy
56,562
+185
+0.3% +$17.3K 0.38% 78
2018
Q3
$5.55M Sell
56,377
-1,575
-3% -$146K 0.35% 90
2018
Q2
$4.96M Sell
57,952
-1,045
-2% -$87.3K 0.37% 84
2018
Q1
$4.73M Sell
58,997
-770
-1% -$63.5K 0.33% 93
2017
Q4
$4.83M Buy
59,767
+776
+1% +$62.1K 0.33% 90
2017
Q3
$4.59M Sell
58,991
-783
-1% -$65K 0.34% 92
2017
Q2
$5.3M Sell
59,774
-1,041
-2% -$87.8K 0.41% 84
2017
Q1
$4.9M Sell
60,815
-2,006
-3% -$157K 0.39% 84
2016
Q4
$4.48M Sell
62,821
-72,795
-54% -$5.72M 0.37% 83
2015
Q4
$10.4M Sell
135,616
-9,689
-7% -$729K 1.08% 32
2014
Q4
$10.5M Sell
145,305
-17,910
-11% -$1.24M 1.12% 35
2013
Q4
$9.37M Hold
163,215
– – 1.08% 37

Other funds holding MDT

Glenview Trust's MDT Position: Q3 2026 in Review

Glenview Trust increased its Medtronic (MDT) stake by 1.3% in Q3 2026, buying an estimated $56.1K and bringing the position to 48,703 shares worth $4.2M. The position accounts for 0.06% of the portfolio, ranked #173.

Glenview Trust first reported a position in MDT in Q4 2013 and has held it in 43 quarters since. The position peaked at $25.3M in Q3 2021. 2,203 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Glenview Trust held 48,703 shares of Medtronic worth $4.2M as of Q3 2026.
  • Glenview Trust bought 637 Medtronic shares in Q3 2026, an estimated $56.1K.
  • Medtronic made up 0.06% of Glenview Trust's portfolio in Q3 2026, its #173 holding.
  • Glenview Trust first reported a position in Medtronic in Q4 2013 and has held it in 43 quarters since.
  • Glenview Trust's Medtronic position peaked at $25.3M in Q3 2021.
  • 2,203 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Glenview Trust's 13F filing for Q3 2026, filed 28 Oct 2026.